ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurologic Disorders Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-30S13903
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Neurologic Disorders Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Neurologic Disorders Therapeutics Market Research Report 2024

Code: QYRE-Auto-30S13903
Report
January 2024
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
F Hoffmann La Roche Ltd
Johnson & Johnson Services Inc.
Novartis
Pfizer Inc

Neurologic Disorders Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neurologic Disorders Therapeutics Market

Neurologic Disorders Therapeutics Market

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
The global Neurologic Disorders Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neurologic Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurologic Disorders Therapeutics.

Report Scope

The Neurologic Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurologic Disorders Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurologic Disorders Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurologic Disorders Therapeutics Market Report

Report Metric Details
Report Name Neurologic Disorders Therapeutics Market
CAGR 5%
Segment by Type
  • Central Nervous System (CNS)
  • Peripheral Nervous System (PNS)
Segment by Application
  • Paralysis
  • Muscle Weakness
  • Poor Coordination
  • Loss of Sensation
  • Seizures
  • Confusion
  • Pain and Altered Levels of Consciousness
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurologic Disorders Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurologic Disorders Therapeutics Market report?

Ans: The main players in the Neurologic Disorders Therapeutics Market are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc.

What are the Application segmentation covered in the Neurologic Disorders Therapeutics Market report?

Ans: The Applications covered in the Neurologic Disorders Therapeutics Market report are Paralysis, Muscle Weakness, Poor Coordination, Loss of Sensation, Seizures, Confusion, Pain and Altered Levels of Consciousness

What are the Type segmentation covered in the Neurologic Disorders Therapeutics Market report?

Ans: The Types covered in the Neurologic Disorders Therapeutics Market report are Central Nervous System (CNS), Peripheral Nervous System (PNS)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Central Nervous System (CNS)
1.2.3 Peripheral Nervous System (PNS)
1.3 Market by Application
1.3.1 Global Neurologic Disorders Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Paralysis
1.3.3 Muscle Weakness
1.3.4 Poor Coordination
1.3.5 Loss of Sensation
1.3.6 Seizures
1.3.7 Confusion
1.3.8 Pain and Altered Levels of Consciousness
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurologic Disorders Therapeutics Market Perspective (2019-2030)
2.2 Neurologic Disorders Therapeutics Growth Trends by Region
2.2.1 Global Neurologic Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurologic Disorders Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Neurologic Disorders Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Neurologic Disorders Therapeutics Market Dynamics
2.3.1 Neurologic Disorders Therapeutics Industry Trends
2.3.2 Neurologic Disorders Therapeutics Market Drivers
2.3.3 Neurologic Disorders Therapeutics Market Challenges
2.3.4 Neurologic Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurologic Disorders Therapeutics Players by Revenue
3.1.1 Global Top Neurologic Disorders Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurologic Disorders Therapeutics Revenue
3.4 Global Neurologic Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorders Therapeutics Revenue in 2023
3.5 Neurologic Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Neurologic Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Neurologic Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurologic Disorders Therapeutics Breakdown Data by Type
4.1 Global Neurologic Disorders Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2025-2030)
5 Neurologic Disorders Therapeutics Breakdown Data by Application
5.1 Global Neurologic Disorders Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurologic Disorders Therapeutics Market Size (2019-2030)
6.2 North America Neurologic Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
6.4 North America Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurologic Disorders Therapeutics Market Size (2019-2030)
7.2 Europe Neurologic Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
7.4 Europe Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Neurologic Disorders Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurologic Disorders Therapeutics Market Size (2019-2030)
9.2 Latin America Neurologic Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Neurologic Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Detail
11.1.2 Biogen Inc. Business Overview
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Introduction
11.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.1.5 Biogen Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Detail
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Detail
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.3.5 Johnson & Johnson Services Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Neurologic Disorders Therapeutics Introduction
11.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.5.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Biogen
F Hoffmann La Roche Ltd
Johnson & Johnson Services Inc.
Novartis
Pfizer Inc
List of Tables
    Table 1. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Central Nervous System (CNS)
    Table 3. Key Players of Peripheral Nervous System (PNS)
    Table 4. Global Neurologic Disorders Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Neurologic Disorders Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Neurologic Disorders Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Neurologic Disorders Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Neurologic Disorders Therapeutics Market Share by Region (2025-2030)
    Table 10. Neurologic Disorders Therapeutics Market Trends
    Table 11. Neurologic Disorders Therapeutics Market Drivers
    Table 12. Neurologic Disorders Therapeutics Market Challenges
    Table 13. Neurologic Disorders Therapeutics Market Restraints
    Table 14. Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Neurologic Disorders Therapeutics Market Share by Players (2019-2024)
    Table 16. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorders Therapeutics as of 2023)
    Table 17. Ranking of Global Top Neurologic Disorders Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Neurologic Disorders Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Neurologic Disorders Therapeutics Product Solution and Service
    Table 21. Date of Enter into Neurologic Disorders Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Neurologic Disorders Therapeutics Revenue Market Share by Application (2019-2024)
    Table 29. Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Neurologic Disorders Therapeutics Revenue Market Share by Application (2025-2030)
    Table 31. North America Neurologic Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Neurologic Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Neurologic Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Neurologic Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Neurologic Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Biogen Inc. Company Detail
    Table 47. Biogen Inc. Business Overview
    Table 48. Biogen Inc. Neurologic Disorders Therapeutics Product
    Table 49. Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 50. Biogen Inc. Recent Development
    Table 51. F. Hoffmann-La Roche Ltd. Company Detail
    Table 52. F. Hoffmann-La Roche Ltd. Business Overview
    Table 53. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product
    Table 54. F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 55. F. Hoffmann-La Roche Ltd. Recent Development
    Table 56. Johnson & Johnson Services Inc. Company Detail
    Table 57. Johnson & Johnson Services Inc. Business Overview
    Table 58. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product
    Table 59. Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 60. Johnson & Johnson Services Inc. Recent Development
    Table 61. Novartis AG Company Detail
    Table 62. Novartis AG Business Overview
    Table 63. Novartis AG Neurologic Disorders Therapeutics Product
    Table 64. Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 65. Novartis AG Recent Development
    Table 66. Pfizer Inc. Company Detail
    Table 67. Pfizer Inc. Business Overview
    Table 68. Pfizer Inc. Neurologic Disorders Therapeutics Product
    Table 69. Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. Pfizer Inc. Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurologic Disorders Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Neurologic Disorders Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Central Nervous System (CNS) Features
    Figure 4. Peripheral Nervous System (PNS) Features
    Figure 5. Global Neurologic Disorders Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Neurologic Disorders Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Paralysis Case Studies
    Figure 8. Muscle Weakness Case Studies
    Figure 9. Poor Coordination Case Studies
    Figure 10. Loss of Sensation Case Studies
    Figure 11. Seizures Case Studies
    Figure 12. Confusion Case Studies
    Figure 13. Pain and Altered Levels of Consciousness Case Studies
    Figure 14. Neurologic Disorders Therapeutics Report Years Considered
    Figure 15. Global Neurologic Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Neurologic Disorders Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Neurologic Disorders Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global Neurologic Disorders Therapeutics Market Share by Players in 2023
    Figure 19. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorders Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Neurologic Disorders Therapeutics Revenue in 2023
    Figure 21. North America Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 27. Germany Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Neurologic Disorders Therapeutics Market Share by Region (2019-2030)
    Figure 35. China Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 43. Mexico Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 47. Turkey Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Biogen Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 51. Johnson & Johnson Services Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 52. Novartis AG Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 53. Pfizer Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Tardive Dystonia Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18L14247
Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Disjointed Aneurysm Clip Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25Z14384
Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Amyotrophic Lateral Sclerosis (ALS) Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34J15350
Tue Aug 13 00:00:00 UTC 2024

Add to Cart

Global Visual Electrodiagnostic System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29Y17645
Tue Aug 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions